1887

Abstract

Conversion of the cellular isoform of the prion protein (PrP) into the pathogenic isoform (PrP) is thought to be the causative event in prion diseases. Biochemically, PrP differs from PrP in its partial resistance to proteinase K (PK). The amino acid sequence AGAAAAGA, comprising residues 112–119 of the murine PrP, has been shown to be amyloidogenic and evolutionarily conserved. To assess the effect of mutations at and around this hydrophobic sequence on protease resistance, the sequence was replaced either by alanines or by glycines and, in a third mutant, a large part surrounding this region was removed. The PrP mutant carrying substitutions of glycines for alanines showed PK resistance and aberrant proteolytic processing. Tetracycline-induced expression of this mutant indicated that resistance to protease is acquired concurrent with the synthesis of the protein. These findings indicate that mutations in the central hydrophobic region lead to immediate alterations in PrP structure and processing.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-5-1237
2002-05-01
2020-08-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/5/0831237a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-5-1237&mimeType=html&fmt=ahah

References

  1. Borchelt D. R., Scott D., Taraboulos A., Stahl N., Prusiner S. B.. 1990; Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. Journal of Cell Biology110:743–752
    [Google Scholar]
  2. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A.. 1996; Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature379:339–343
    [Google Scholar]
  3. Brown D. R.. 2000a; Prion protein peptides: optimal toxicity and peptide blockade of toxicity. Molecular and Cellular Neurosciences15:66–78
    [Google Scholar]
  4. Brown D. R.. 2000b; PrPSc-like prion protein peptide inhibits the function of cellular prion protein. Biochemical Journal352:511–518
    [Google Scholar]
  5. Brown D. R., Schmidt B., Kretzschmar H. A.. 1996; Role of microglia and host prion protein in neurotoxicity of prion protein fragment. Nature380:345–347
    [Google Scholar]
  6. Brown D. R., Qin K., Herms J. W., Madlung A., Manson J., Strome R., Fraser P. E., Kruck T., von Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D., Kretzschmar H.. 1997a; The cellular prion protein binds copper in vivo . Nature390:684–687
    [Google Scholar]
  7. Brown D. R., Schulz-Schaeffer W. J., Schmidt B., Kretzschmar H. A.. 1997b; Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Experimental Neurology146:104–112
    [Google Scholar]
  8. Büeler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., Weissmann C.. 1993; Mice devoid of PrP are resistant to scrapie. Cell73:1339–1347
    [Google Scholar]
  9. Büeler H., Raeber A., Sailer A., Fischer M., Aguzzi A., Weissmann C.. 1994; High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Molecular Medicine1:19–30
    [Google Scholar]
  10. Caughey B., Race R. E., Ernst D., Buchmeier M. J., Chesebro B.. 1989; Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. Journal of Virology63:175–181
    [Google Scholar]
  11. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., Caughey W. S.. 1991; Secondary structure analysis of the scrapie-associated protein PrP27–30 in water by infrared spectroscopy. Biochemistry30:7672–7680
    [Google Scholar]
  12. Chabry J., Caughey B., Chesebro B.. 1998; Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. Journal of Biological Chemistry273:13203–13207
    [Google Scholar]
  13. Chen S. G., Teplow D. B., Parchi P., Teller J. K., Gambetti P., Autilio-Gambetti L.. 1995; Truncated forms of the human prion protein in normal brain and in prion diseases. Journal of Biological Chemistry270:19173–19180
    [Google Scholar]
  14. Daude N., Lehmann S., Harris D. A.. 1997; Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. Journal of Biological Chemistry272:11604–11612
    [Google Scholar]
  15. Donne D. G., Viles J. H., Groth D., Mehlhorn I., James T. L., Cohen F. E., Prusiner S. B., Wright P. E., Dyson H. J.. 1997; Structure of recombinant full-length hamster prion protein PrP(29–231): the N terminus is highly flexible. Proceedings of the National Academy of Sciences, USA94:13452–13457
    [Google Scholar]
  16. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F.. 1993; Neurotoxicity of a prion protein fragment. Nature362:543–546
    [Google Scholar]
  17. Gasset M., Baldwin M. A., Lloyd D. H., Gabriel J.-M., Holtzman D. M., Cohen F., Fletterick R., Prusiner S. B.. 1992; Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proceedings of the National Academy of Sciences, USA89:10940–10944
    [Google Scholar]
  18. Haraguchi T., Fisher S., Olofsson S., Endo T., Groth D., Tarentino A., Borchelt D. R., Teplow D., Hood L., Burlingame A., Lycke E., Kobata A., Prusiner S. B.. 1989; Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Archives of Biochemistry and Biophysics274:1–13
    [Google Scholar]
  19. Harris D. A., Huber M. T., van Dijken P., Shyng S. L., Chait B. T., Wang R.. 1993; Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry32:1009–1016
    [Google Scholar]
  20. Hegde R. S., Mastrianni J. A., Scott M. R., DeFea K. A., Tremblay P., Torchia M., DeArmond S. J., Prusiner S. B., Lingappa V. R.. 1998; A transmembrane form of the prion protein in neurodegenerative disease. Science279:827–834
    [Google Scholar]
  21. Hegde R. S., Tremblay P., Groth D., DeArmond S. J., Prusiner S. B., Lingappa V. R.. 1999; Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature402:822–826
    [Google Scholar]
  22. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., Schürmann P., Windl O., Brose N., Kretzschmar H.. 1999; Evidence of presynaptic location and function of the prion protein. Journal of Neuroscience19:8866–8875
    [Google Scholar]
  23. Higuchi R., Krummel B., Saiki R. K.. 1988; A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Research16:7351–7367
    [Google Scholar]
  24. Hölscher C., Delius H., Bürkle A.. 1998; Overexpression of nonconvertible PrPcΔ114–121 in scrapie-infected mouse neuroblastoma cells leads to trans -dominant inhibition of wild-type PrPSc accumulation. Journal of Virology72:1153–1159
    [Google Scholar]
  25. Hornemann S., Korth C., Oesch B., Riek R., Wider G., Wüthrich K., Glockshuber R.. 1997; Recombinant full-length murine prion protein, mPrP(23–231): purification and spectroscopic characterization. FEBS Letters413:277–281
    [Google Scholar]
  26. Ivanova L., Barmada S., Kummer T., Harris D. A.. 2001; Mutant prion proteins are partially retained in the endoplasmic reticulum. Journal of Biological Chemistry276:42409–42421
    [Google Scholar]
  27. Jiménez-Huete A., Lievens P. M. J., Vidal R., Piccardo P., Ghetti B., Tagliavini F., Frangione B., Prelli F.. 1998; Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. American Journal of Pathology153:1561–1572
    [Google Scholar]
  28. Klebe R. J., Ruddle F. H.. 1969; Neuroblastoma: cell culture analysis of a differentiating stem cell system. Journal of Cell Biology43: 69a
    [Google Scholar]
  29. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A., Braun U., Ehrensperger F., Hornemann S., Glockshuber R., Riek R., Billeter M., Wüthrich K., Oesch B.. 1997; Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature390:74–77
    [Google Scholar]
  30. Krasemann S., Groschup M. H., Harmeyer S., Hunsmann G., Bodemer W.. 1996; Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Molecular Medicine2:725–734
    [Google Scholar]
  31. LeGendre N.. 1990; Immobilon-P transfer membrane: applications and utility in protein biochemical analysis. Biotechniques9:788–805
    [Google Scholar]
  32. Lehmann S., Harris D. A.. 1996; Mutant and infectious prion proteins display common biochemical properties in cultured cells. Journal of Biological Chemistry271:1633–1637
    [Google Scholar]
  33. Lehmann S., Harris D. A.. 1997; Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. Journal of Biological Chemistry272:21479–21487
    [Google Scholar]
  34. Liu H., Farr-Jones S., Ulyanov N. B., Llinas M., Marqusee S., Groth D., Cohen F. E., Prusiner S. B., James T. L.. 1999; Solution structure of Syrian hamster prion protein rPrP(90–231). Biochemistry38:5362–5377
    [Google Scholar]
  35. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J. L., Lehmann S., Launay J. M., Kellermann O.. 2000; Signal transduction through prion protein. Science289:1925–1928
    [Google Scholar]
  36. Muramoto T., Scott M., Cohen F. E., Prusiner S. B.. 1996; Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proceedings of the National Academy of Sciences, USA93:15457–15462
    [Google Scholar]
  37. Pan K. M., Stahl N., Prusiner S. B.. 1992; Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Science1:1343–1352
    [Google Scholar]
  38. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., Prusiner S. B.. 1993; Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, USA90:10962–10966
    [Google Scholar]
  39. Petersen R. B., Parchi P., Richardson S. L., Urig C. B., Gambetti P.. 1996; Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. Journal of Biological Chemistry271:12661–12668
    [Google Scholar]
  40. Priola S. A., Chesebro B.. 1998; Abnormal properties of prion protein with insertional mutations in different cell types. Journal of Biological Chemistry273:11980–11985
    [Google Scholar]
  41. Prusiner S. B., DeArmond S. J.. 1994; Prion diseases and neurodegeneration. Annual Review of Neuroscience17:311–339
    [Google Scholar]
  42. Prusiner S. B., Telling G., Cohen F. E., DeArmond S. J.. 1996; Prion diseases of humans and animals. Seminars in Virology7:159–173
    [Google Scholar]
  43. Quaglio E., Chiesa R., Harris D. A.. 2001; Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. Journal of Biological Chemistry276:11432–11438
    [Google Scholar]
  44. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wüthrich K.. 1996; NMR structure of the mouse prion protein domain PrP(121–231). Nature382:180–182
    [Google Scholar]
  45. Riek R., Hornemann S., Wider G., Glockshuber R., Wüthrich K.. 1997; NMR characterization of the full-length recombinant murine prion protein, mPrP(23–231). FEBS Letters413:282–288
    [Google Scholar]
  46. Rogers M., Serban D., Gyuris T., Scott M., Torchia T., Prusiner S. B.. 1991; Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system. Journal of Immunology147:3568–3574
    [Google Scholar]
  47. Safar J., Roller P. P., Gadjusek D. C., Gibbs C.. J.Jr(1993; Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. Journal of Biological Chemistry268:20276–20284
    [Google Scholar]
  48. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Wälchli M., Torchia M., Groth D., Carlson G., DeArmond S. J., Westaway D., Prusiner S. B.. 1989; Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell59:847–857
    [Google Scholar]
  49. Shyng S. L., Huber M. T., Harris D. A.. 1993; A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. Journal of Biological Chemistry268:15922–15928
    [Google Scholar]
  50. Singh N., Zanusso G., Chen S. G., Fujioka H., Richardson S., Gambetti P., Petersen R. B.. 1997; Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. Journal of Biological Chemistry272:28461–28470
    [Google Scholar]
  51. Stewart R. S., Harris D. A.. 2001; Most pathogenic mutations do not alter the membrane topology of the prion protein. Journal of Biological Chemistry276:2212–2220
    [Google Scholar]
  52. Tremblay P., Meiner Z., Galou M., Heinrich C., Petromilli C., Lisse T., Cayetano J., Torchia M., Mobley W., Bujard H., DeArmond S. J., Prusiner S. B.. 1998; Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proceedings of the National Academy of Sciences, USA95:12580–12585
    [Google Scholar]
  53. Viles J. H., Cohen F. E., Prusiner S. B., Goodin D. B., Wright P. E., Dyson H. J.. 1999; Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proceedings of the National Academy of Sciences, USA96:2042–2047
    [Google Scholar]
  54. Windl O., Lorenz H., Behrens C., Römer A., Kretzschmar H. A.. 1999; Construction and characterization of murine neuroblastoma cell clones allowing inducible and high expression of the prion protein. Journal of General Virology80:15–21
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-5-1237
Loading
/content/journal/jgv/10.1099/0022-1317-83-5-1237
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error